Mizuho initiated coverage on Concentra Group Holdings Parent with a new price target
$CON
Medical Specialities
Health Care
Mizuho initiated coverage of Concentra Group Holdings Parent with a rating of Outperform and set a new price target of $28.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/18/2025 | $31.00 | Overweight | Analyst |
| 12/16/2024 | $24.00 | Neutral → Buy | BofA Securities |
| 10/7/2024 | $30.50 → $24.00 | Buy → Neutral | BofA Securities |
| 8/20/2024 | $33.00 | Outperform | RBC Capital Mkts |
| 8/19/2024 | Buy | BofA Securities | |
| 8/19/2024 | $29.00 | Buy | Deutsche Bank |
| 8/19/2024 | $29.00 | Overweight | JP Morgan |
| 8/19/2024 | $32.00 | Buy | Goldman |
Analyst resumed coverage of Concentra with a rating of Overweight and set a new price target of $31.00
BofA Securities upgraded Concentra Group Holdings Parent from Neutral to Buy and set a new price target of $24.00
BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously
4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)
4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)
4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)
Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services by number of locations, today released preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, exceeding its previously issued guidance for full year 2025. In addition, the Company is releasing its preliminary 2026 business outlook, and publishing a detailed Investor Book providing a comprehensive primer on Concentra's business and industry. Concentra will issue its full fourth quarter and fiscal year 2025 financial results on February 26, 2026 and will host a conference call on Februa
Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Tucker, Georgia. The medical center, Concentra Tucker, is conveniently located at 4434 Hugh Howell Road, Tucker, Georgia 30084. "Georgia is a strong market for Concentra," said Janet Cobb, MD, senior vice president of Concentra medical operations. "Expanding to Tucker gives us another access point in DeKalb County and will enable us to reach more Georgia employers and provide quality occupational health services to their workers." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-rel
Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Hialeah, Florida. The medical center, Concentra Hialeah, is conveniently located at 855 East 8th Avenue, Hialeah, Florida 33010. "Hialeah has shown great potential for Concentra," said Janet Cobb, MD, senior vice president of Concentra medical operations. "By optimizing our presence in Hialeah, we intend to serve more employers and provide greater access to care." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related health services from its new location in Hialeah. Telemedicine fo
8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)
8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)
SCHEDULE 13D/A - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)
Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities. "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize
Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services by number of locations, today released preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, exceeding its previously issued guidance for full year 2025. In addition, the Company is releasing its preliminary 2026 business outlook, and publishing a detailed Investor Book providing a comprehensive primer on Concentra's business and industry. Concentra will issue its full fourth quarter and fiscal year 2025 financial results on February 26, 2026 and will host a conference call on Februa
Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 7, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's investor relations website. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:
Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its second quarter ended June 30, 2025, the declaration of a cash dividend, and raised guidance for FY 2025. "Concentra delivered strong results in the second quarter, building on our solid start to 2025," said Keith Newton, Chief Executive Officer of Concentra. "Our results reflected strength across several key measures, including growth in patient visits, rate, revenue, and Adjusted EBITDA. We are well-positioned for continued momentum driven by the disciplined execution of our strategy by our outs
SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)
SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)
SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)